Cargando…
Fragmented Dosing of β-alanine Induces A Body Weight-Independent Pharmacokinetic Response
Personalised dosing of performance-enhancing food supplements is a hot topic. β-alanine is currently dosed using a fixed dose; however, evidence suggests that this might favour light compared to heavy subjects. A weight-relative dose seems to reverse this problem. In the present study, a novel dosin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950400/ https://www.ncbi.nlm.nih.gov/pubmed/31771148 http://dx.doi.org/10.3390/nu11122869 |
_version_ | 1783486063170289664 |
---|---|
author | Stautemas, Jan Van de Loock, Alexia Van der Stede, Thibaux Pringels, Lauren Derave, Wim |
author_facet | Stautemas, Jan Van de Loock, Alexia Van der Stede, Thibaux Pringels, Lauren Derave, Wim |
author_sort | Stautemas, Jan |
collection | PubMed |
description | Personalised dosing of performance-enhancing food supplements is a hot topic. β-alanine is currently dosed using a fixed dose; however, evidence suggests that this might favour light compared to heavy subjects. A weight-relative dose seems to reverse this problem. In the present study, a novel dosing strategy was tested. A fragmented dose, composed of a fixed fragment of 800 mg and a weight-relative fragment of 10 mg/kg body weight, was compared to a fixed dose of 1600 mg and a weight-relative dose of 20 mg/kg body weight in a cohort of 20 subjects with a body weight ranging 48–139 kg (79.9 ± 24.4 kg). The results show that, following a fragmented dose, the influence of body weight on the pharmacokinetic response (iAUC) over a 210 min period was absent (r = −0.168; p = 0.478), in contrast to the fixed or weight-relative dose. The pharmacokinetic response also seemed more homogenous (CV% = 26%) following a fragmented dose compared to the fixed (33%) and the weight-relative dose (31%). The primary advantage of the easy-to-calculate fragmented dosing strategy is that it does not systematically favour or impair a certain weight group. Thorough dosage studies are lacking in the current field of sports and food supplements, therefore similar considerations can be made towards other (ergogenic) food supplements. |
format | Online Article Text |
id | pubmed-6950400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69504002020-01-16 Fragmented Dosing of β-alanine Induces A Body Weight-Independent Pharmacokinetic Response Stautemas, Jan Van de Loock, Alexia Van der Stede, Thibaux Pringels, Lauren Derave, Wim Nutrients Article Personalised dosing of performance-enhancing food supplements is a hot topic. β-alanine is currently dosed using a fixed dose; however, evidence suggests that this might favour light compared to heavy subjects. A weight-relative dose seems to reverse this problem. In the present study, a novel dosing strategy was tested. A fragmented dose, composed of a fixed fragment of 800 mg and a weight-relative fragment of 10 mg/kg body weight, was compared to a fixed dose of 1600 mg and a weight-relative dose of 20 mg/kg body weight in a cohort of 20 subjects with a body weight ranging 48–139 kg (79.9 ± 24.4 kg). The results show that, following a fragmented dose, the influence of body weight on the pharmacokinetic response (iAUC) over a 210 min period was absent (r = −0.168; p = 0.478), in contrast to the fixed or weight-relative dose. The pharmacokinetic response also seemed more homogenous (CV% = 26%) following a fragmented dose compared to the fixed (33%) and the weight-relative dose (31%). The primary advantage of the easy-to-calculate fragmented dosing strategy is that it does not systematically favour or impair a certain weight group. Thorough dosage studies are lacking in the current field of sports and food supplements, therefore similar considerations can be made towards other (ergogenic) food supplements. MDPI 2019-11-23 /pmc/articles/PMC6950400/ /pubmed/31771148 http://dx.doi.org/10.3390/nu11122869 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stautemas, Jan Van de Loock, Alexia Van der Stede, Thibaux Pringels, Lauren Derave, Wim Fragmented Dosing of β-alanine Induces A Body Weight-Independent Pharmacokinetic Response |
title | Fragmented Dosing of β-alanine Induces A Body Weight-Independent Pharmacokinetic Response |
title_full | Fragmented Dosing of β-alanine Induces A Body Weight-Independent Pharmacokinetic Response |
title_fullStr | Fragmented Dosing of β-alanine Induces A Body Weight-Independent Pharmacokinetic Response |
title_full_unstemmed | Fragmented Dosing of β-alanine Induces A Body Weight-Independent Pharmacokinetic Response |
title_short | Fragmented Dosing of β-alanine Induces A Body Weight-Independent Pharmacokinetic Response |
title_sort | fragmented dosing of β-alanine induces a body weight-independent pharmacokinetic response |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950400/ https://www.ncbi.nlm.nih.gov/pubmed/31771148 http://dx.doi.org/10.3390/nu11122869 |
work_keys_str_mv | AT stautemasjan fragmenteddosingofbalanineinducesabodyweightindependentpharmacokineticresponse AT vandeloockalexia fragmenteddosingofbalanineinducesabodyweightindependentpharmacokineticresponse AT vanderstedethibaux fragmenteddosingofbalanineinducesabodyweightindependentpharmacokineticresponse AT pringelslauren fragmenteddosingofbalanineinducesabodyweightindependentpharmacokineticresponse AT deravewim fragmenteddosingofbalanineinducesabodyweightindependentpharmacokineticresponse |